2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Nasdaq notified Roman DBDR Acquisition Corp. II on August 19, 2026, that it does not maintain the minimum of 400 holders required for continued listing. The notice has no immediate effect on the listing of the company's securities on the Nasdaq Global Market, but the company must submit a compliance plan, and failure to regain compliance could ultimately lead to delisting.
Nasdaq deficiency letter received August 19, 2026, under Listing Rule 5450(a)(2)
Compliance plan due to Nasdaq by October 5, 2026
If the plan is accepted, Nasdaq can grant an exception until February 15, 2027
If Nasdaq rejects the plan, the company may appeal to a Nasdaq Hearings Panel
ZeroStack Corp. filed an 8-K under Item 8.01 that repeats disclosure previously included in its Form S-3 registration statement filed August 21, 2026, and supplements its 2025 Form 10-K and 2026 quarterly reports. The filing contains no new financial results, guidance, or transaction terms, and centers on risk factors tied to the price volatility of its 0G and MemeCore token holdings, going-concern risk, and possible delisting.
The disclosure was previously included in Form S-3 File No. 333-298482, filed August 21, 2026.
The filing directs readers to the 2025 Annual Report, filed with the SEC on February 27, 2026, and the quarterly reports for March 31, 2026 and June 30, 2026.
Risk factors cite volatility in 0G and MemeCore prices, the company's ability to continue as a going concern, and potential delisting of its common stock.
On August 20, 2026, subsidiary Starling Oncology Management, LLC entered a revolving credit agreement with Gemino Healthcare Finance, LLC (d/b/a SLR Healthcare ABL) for up to $25 million. The filing says the company is not required or expected to borrow the full amount, and that it is intended to provide financial flexibility if needed. Shareholders should note the facility is secured by substantially all of the subsidiary's assets and carries a covenant on loan turn days.
Facility of up to $25 million, dated August 20, 2026, maturing August 20, 2029
Interest at Term SOFR plus 3.95%, with Term SOFR floored at 2.00% per annum
$4,750,000 outstanding as of August 21, 2026 (the filing text reads "$4,750,000 million")
Secured by a first-priority security interest in substantially all of the subsidiary's collateral; covenant limits Maximum Loan Turn Days to 35 on a rolling three-month basis
Nerdy Inc. said on August 20, 2026, that it had notified Chief Operating Officer John Paszterko of its decision to end his service in that role, effective immediately. The filing does not give a reason for the decision or name a successor, so shareholders have no stated information on how operations leadership will be handled.
The Company notified John Paszterko of the decision on August 20, 2026.
His service as Chief Operating Officer ends effective immediately.
The filing does not state a reason for the change or name a replacement.
The 8-K was signed on August 21, 2026, by Chief Legal Officer and Corporate Secretary Christopher C. Swenson.
GEE Group entered a cooperation agreement with Star Equity Fund on August 21, 2026. Star Equity Fund withdrew its director nominee and its proposal to remove two directors at the 2026 Annual Meeting, and agreed to standstill and voting commitments. The company agreed to phase in declassification of its board, which will change how directors are elected going forward.
Star Equity Fund withdrew its director nominee and its business proposal to remove two GEE Group directors at the 2026 Annual Meeting.
Star Equity Fund agreed not to acquire more than 7.5% of outstanding Common Stock and to other customary standstill terms.
A majority of the board will be declassified at the 2027 Annual Meeting and the board will be fully declassified at the 2028 Annual Meeting, per the press release.
The agreement ends on the earlier of the opening of the advance notice period for 2027 director nominations or 120 days before the one-year anniversary of the 2026 Annual Meeting.
Global Water Resources agreed on August 20, 2026 to sell 1,129,944 shares of common stock at $8.85 per share, for about $10 million in total, in a private placement. The buyers include Levine Investments Limited Partnership and Andrew M. Cohn, who are linked to directors Jonathan L. Levine and Andrew M. Cohn, so existing shareholders should note that insiders are among the purchasers and that the new shares add to the shares outstanding.
1,129,944 shares of common stock sold at $8.85 per share, about $10 million in aggregate, under a Securities Purchase Agreement dated August 20, 2026
Sold in a private placement exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506; all purchasers are accredited investors
Purchasers include Levine Investments Limited Partnership and Andrew M. Cohn; director Jonathan L. Levine is a limited partner of the partnership and director of its general partner, Keim Inc., and director Andrew M. Cohn is its Director of
Price set at the Nasdaq closing bid price immediately before the agreement was entered into
Zeo Energy Corp. amended its Common Stock Purchase Agreement with White Lion Capital, LLC on August 20, 2026. The amendment lets the company set a floor price, in its sole discretion, for shares sold under an Accelerated Purchase Notice; previously it had no such discretion. The original agreement allows the company to require White Lion to buy up to $30.0 million of newly issued Class A Common Stock.
Amendment No. 1 dated August 20, 2026, with White Lion Capital, LLC, filed as Exhibit 10.1
Minimum purchase price per share must be not lower than a floor price the company sets in its sole discretion and the price in the applicable notice
Original Purchase Agreement, disclosed January 27, 2026, covers up to $30.0 million in aggregate gross purchase price
SolarMax Technology received a Nasdaq notice on August 20, 2026, because it has not filed its Form 10-Q for the quarter ended June 30, 2026. The company has until October 19, 2026 to submit a plan to regain compliance, and Nasdaq could grant an exception to February 16, 2027 if it accepts that plan. The filing also discloses two earlier Nasdaq deficiencies, a bid price issue and a market value of listed securities issue, so shareholders face several open listing requirements at once.
Nasdaq notice dated August 20, 2026 cites Listing Rule 5250(c)(1) for the missing 10-Q for the quarter ended June 30, 2026
Plan to regain compliance due October 19, 2026; Nasdaq could allow an exception up to February 16, 2027 if the plan is accepted
Bid price deficiency notice received March 3, 2026; compliance deadline August 31, 2026; one-for-12 reverse stock split effected August 13, 2026
Market value of listed securities notice received June 22, 2026; compliance deadline December 21, 2026
Mangoceuticals and Nuclea Energy mutually agreed on August 19, 2026 to terminate their Business Combination Agreement, which had been dated July 29, 2026. The parties said the $15,000,000 PIPE financing minimum could not be raised by the August 21, 2026 outside date, so the financing closing condition could not be met on the agreed terms.
Termination agreed August 19, 2026 under Section 12.1(a) of the agreement, which was dated July 29, 2026
Closing required PIPE financing of at least $15,000,000 deposited into escrow; the outside date was August 21, 2026
Each party bears its own costs, and the parties exchanged mutual releases except for willful breaches before termination
Dream Finders Homes' board approved amendments to its 2021 Equity Incentive Plan, including a higher $400,000 annual cap on non-employee director compensation for the Chairman, Co-Chairman, Lead Director or similar roles. A majority shareholder approved the director pay change by written consent on August 20, 2026, with a Schedule 14C information statement to follow before it takes effect. The other changes are administrative: moving governing law from Delaware to Texas and revising the definition of Fair Market Value.
Director Compensation Limit for chair-level and lead director roles set at $400,000 per fiscal year
Majority shareholder approved the director pay amendment by written consent on August 20, 2026
Director pay change takes effect at least 20 calendar days after the information statement is mailed to shareholders
Governing law changed from Delaware to Texas and Fair Market Value definition revised, effective August 20, 2026
Boeing appointed Ryan L. Shedd, a former Ernst & Young Assurance Partner, as Senior Vice President and Controller, effective after the Company files its 2026 Form 10-K. He will also serve as principal accounting officer, succeeding Michael J. Cleary, who plans to retire in 2027. The change concerns the company's top accounting role, but the filing reports no financial results.
Ryan L. Shedd, age 41, appointed August 19, 2026; joins in September 2026 as Senior Vice President, Finance
Effective date is the first business day after Boeing files its Form 10-K for the year ended December 31, 2026
Michael J. Cleary, Senior Vice President and Controller since March 2023, plans to retire in 2027
Shedd's pay includes a $600,000 base salary, a 70% target annual incentive, a 170% target long-term incentive from 2027, and a $300,000 cash sign-on award
Northrop Grumman's independent directors approved a one-time performance-based equity grant to Chair, CEO and President Kathy J. Warden on August 19, 2026. The award pays out based on the company's absolute stock price change through December 31, 2031, and is tied to her continued service, which links her pay directly to shareholder returns.
Award approved by independent directors on August 19, 2026; disclosed in an 8-K dated August 21, 2026
Target award is 35,910 Market Stock Units (MSUs), with payout ranging from 0% to 150% of target
Performance period ends December 31, 2031; full target payout requires at least 10% stock price appreciation
Payout is 0% if the stock falls more than 25% and 150% if it rises 50% or more
Pasithea Therapeutics Corp. received a 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, moving the deadline from August 19, 2026 to February 16, 2027. The company says it may consider a reverse stock split, and if it does not regain compliance, Nasdaq could begin delisting proceedings, though the company says there is no assurance it will meet the new deadline.
Nasdaq letter dated February 20, 2026 flagged closing bid price below $1.00 for 30 consecutive business days.
Original compliance deadline was August 19, 2026; extension granted in an August 20, 2026 Nasdaq letter to February 16, 2027.
Company may consider a reverse stock split; if not compliant by the deadline, Nasdaq would issue a delisting notice that the company could appeal to a hearings panel.
Elutia completed the sale of its SimpliDerm breast reconstruction business, which made up substantially all of its Women's Health segment, to Cellution Biologics on August 17, 2026. The company received $7.7 million in cash at closing, subject to post-closing adjustments, with up to $3 million more in contingent payments. The filing says the company's 2025 and first-half 2026 pro forma continuing operations exclude the business, which had accounted for most of its reported net sales.
Net cash received at closing: $7.7 million, subject to post-closing inventory adjustments
Contingent payments of up to $3 million over the next 18 months, tied to technology transfer and commercial milestones
Pro forma six-month 2026 net sales from continuing operations: $2.2 million, versus $5.5 million as reported
Company expects to record an estimated gain of $4.9 million, which is not reflected in the pro forma periods
Estrella Immunopharma received a Nasdaq notice on August 17, 2026, stating its common stock closed below $1.00 for 30 consecutive business days, so it no longer meets the minimum bid price requirement. The notice has no immediate effect on trading, and the company has until February 16, 2027 to regain compliance, which could involve a reverse stock split.
Nasdaq letter dated August 17, 2026 cites closing bid price below $1.00 from July 6, 2026 through August 14, 2026
Compliance period runs 180 calendar days, until February 16, 2027
Common stock continues to trade on The Nasdaq Capital Market under the symbol ESLA
If not compliant by the deadline, the company may be eligible for a second 180-day period, or face delisting notice and an appeal
Phillips 66 Company, a subsidiary of Phillips 66, amended its accounts receivable securitization program on August 20, 2026. The amendment raises the committed facility from $1.75 billion to $2 billion, adds an uncommitted facility of up to $250 million, and extends the maturity from September 28, 2026 to August 19, 2027.
Maximum committed facility size increased from $1.75 billion to $2 billion
Uncommitted facility of up to $250 million established
Maturity extended from September 28, 2026 to August 19, 2027
Agreement is with PNC Bank, National Association, as administrative agent
James River Group Holdings disclosed that director Kirstin M. Gould resigned effective immediately, with notice given on August 20, 2026, and that the resignation did not stem from a disagreement with the company. The company also furnished a second quarter 2026 investor presentation, which shows net income to common shareholders rose to $4.4 million from $2.8 million a year earlier, but an underwriting loss of $0.3 million and a six-month loss to common shareholders of $6.5 million.
Kirstin M. Gould resigned as a director effective immediately, as of August 20, 2026; the filing states no disagreement with the company.
2Q26 net income to common shareholders was $4.4 million, versus $2.8 million in 2Q25.
2Q26 underwriting result was a loss of $0.3 million, compared with a profit of $2.1 million in 2Q25.
Six months ended June 30, 2026: loss to common shareholders of $6.5 million, versus income of $10.4 million a year earlier; group combined ratio was 100.2% versus 98.6%.
JAB Acquisition Corp I entered a trademark settlement agreement on August 17, 2026, with a third party over its name and trading symbol, and reported it in an August 21, 2026 filing. Under the agreement, the company has asked Nasdaq to change its ticker and intends to rename itself Atlantic Acquisition Corp I, effective once its board and shareholders approve. The filing says current shareholders need take no action and that share ownership percentages and the capital structure are unaffected.
Settlement agreement dated August 17, 2026, with a third party identified as the Claimant
Company has requested a voluntary ticker change from Nasdaq; no effective date has been announced
Proposed new ticker symbols are listed as ATLQ, ATLQU, ATLQW and ATLQR, the same as the current symbol for the shares
Name change to Atlantic Acquisition Corp I requires board and shareholder approval; CIK number remains unchanged
NexGel terminated CEO Adam R. Levy without Cause effective August 21, 2026, and Levy resigned from the Board. The Board appointed director Brian Kieser as Interim CEO, and formed a Special Committee to review strategic alternatives, liquidity and non-core assets.
Levy's employment was terminated without Cause effective August 21, 2026; he also resigned from the Board and all other company positions.
Brian Kieser, a Board member since May 6, 2026, is Interim CEO. He is also CEO of Sequence LifeScience, which has a strategic partnership with NexGel.
The Special Committee, chaired by Kevin Harris with Steve Glassman, expects to present a strategic and value creation framework to the Board within 30 to 45 days.
The separation agreement with Levy and Kieser's compensation terms have not been finalized; the company will file an 8-K amendment once they are.
Nuvectis Pharma entered an agreement with Jefferies LLC on August 21, 2026, allowing it to sell up to $200 million of common stock through a new shelf registration. The company also ended its prior at-the-market program on July 20, 2026. Sales are not guaranteed, and shareholders could face dilution if shares are sold.
Open Market Sale Agreement with Jefferies LLC as sales agent, dated August 21, 2026
New Form S-3 shelf registration covering $200 million in securities, filed August 21, 2026
Jefferies fee of up to 3.0% of gross proceeds from ATM share sales
Prior at-the-market program terminated July 20, 2026; no further sales under it
On August 21, 2026, Alexandria Real Estate Equities issued and sold $1 billion of 7.250% Series A Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2057 in a registered public offering. The notes are unsecured, rank below all existing and future senior debt, and carry a rate that resets after February 15, 2032, which adds a long-term debt obligation for shareholders to weigh.
Principal amount: $1,000,000,000 of notes, issued and sold on August 21, 2026
Interest at 7.250% per year until February 15, 2032, then resets to the five-year U.S. Treasury rate plus 2.889%, with the rate not resetting below 7.250%
Interest payable semi-annually on February 15 and August 15, beginning February 15, 2027; notes mature February 15, 2057
Notes are junior subordinated and guaranteed on a subordinated unsecured basis by Alexandria Real Estate Equities, L.P.; trustee is U.S. Bank Trust Company, National Association
Virtu Financial's Board appointed Barbara Finigan as an independent Class I director on August 19, 2026, effective immediately. The Board now has eleven directors, and the company has entered into a standard indemnification agreement with her.
Barbara Finigan appointed to the Board as a Class I independent director on August 19, 2026, effective immediately
Finigan was previously Chief Legal Officer at Hasbro, Inc. from December 2010 to March 2019
Board size is now eleven directors; the company may add more as business needs arise
Finigan will receive non-employee director compensation similar to that described in the April 29, 2026 proxy statement
Rain Enhancement Technologies Holdco received a Nasdaq notice on August 18, 2026 stating it had not regained compliance with the $35 million market value of listed securities requirement. Unless the company obtained a hearing, its shares would face suspension and delisting from the Nasdaq Capital Market on August 27, 2026. The company requested a hearing before the Nasdaq Hearings Panel on August 21, 2026, and expects this to stay any delisting action, but the filing says the panel may not grant continued listing.
Nasdaq notice received August 18, 2026 said the company had not regained compliance with the $35,000,000 MVLS threshold.
Compliance deadline was August 17, 2026, after a 180-calendar-day period that started with a February 18, 2026 notice.
Company requested a hearing before the Nasdaq Hearings Panel on August 21, 2026.
Scheduled suspension and delisting date is August 27, 2026, unless a stay applies; the company says there is no assurance the panel will grant continued listing.
loanDepot, Inc. (NYSE: LDI) received a written notice from the New York Stock Exchange on August 21, 2026, saying its Class A common stock failed the $1.00 minimum price standard because its average closing price was below $1.00 over 30 consecutive trading days. The company has six months to regain compliance, and if it cannot, the NYSE will begin procedures to suspend and delist the stock, which matters to shareholders because it sets a firm deadline for a share price recovery or a possible reverse stock split.
The NYSE notice was received August 21, 2026, and the company said the average closing price was below $1.00 as of August 20, 2026.
The company has a six-month cure period to bring its share price and average share price back to at least $1.00.
The company must notify the NYSE of its intent to cure within 10 business days of receiving the notice.
A reverse stock split is among the options the company will consider; it would need stockholder approval no later than the next annual meeting, anticipated for early June 2027.
Hinge Health entered an office lease on August 18, 2026 for about 119,278 rentable square feet at 300 Mission Street in San Francisco. Estimated base rent over the term is about $86.0 million, plus operating costs, and the lease is expected to expire February 28, 2037.
Estimated base rent over the lease term is about $86.0 million, plus the company's share of operating expenses, taxes and insurance
Landlord provides a tenant improvement allowance of up to $17.9 million
Company must post a $2.8 million irrevocable standby letter of credit to secure the lease
One five-year renewal option and a one-time early termination right effective January 31, 2035, subject to conditions including a termination payment
Evolution Petroleum completed its previously announced acquisition of mineral and royalty interests in the Midland Basin, Texas, on August 20, 2026, for a total purchase price of $16 million, subject to customary post-closing adjustments. The company says the interests are expected to generate about $3.9 million of next-twelve-month asset-level cash flow and that the deal is immediately accretive to cash flow per share, though these are management estimates.
Total purchase price of $16 million, with an effective date of August 1, 2026
Interests span about 3,420 net royalty acres across five Texas counties and include royalties on an estimated 832 producing wells
Expected next-twelve-month asset-level cash flow of about $3.9 million, an acquisition multiple of about 4.1x, per company estimate
Funded with net proceeds from a recent public stock offering, cash on hand and revolver borrowings; pro forma liquidity about $19 million
Enova's subsidiary NetCredit Combined Receivables B, LLC issued $300,886,000 in 2026-A Notes on August 21, 2026, secured by about $316.72 million of unsecured consumer installment loans. The notes carry fixed coupons from 5.88% to 10.64% and mature September 20, 2032, and are obligations of the issuer only, not guaranteed by Enova. The filing describes a debt financing, and it does not state any effect on Enova's earnings or guidance.
Issued $300,886,000 of notes: $240,709,000 Class A, $44,341,000 Class B, $15,836,000 Class C
Fixed coupons: Class A 5.88%, Class B 7.68%, Class C 10.64% per annum
Final maturity September 20, 2032; indenture trustee is Citibank, N.A.
Notes are not guaranteed by Enova and were sold only to qualified institutional buyers and non-U.S. persons
Global Interactive Technologies (GITS) received a Nasdaq notice on August 20, 2026, because it did not timely file its Form 10-Q for the quarter ended June 30, 2026, which Nasdaq Listing Rule 5250(c)(1) requires for continued listing. The company says it expects to file the 10-Q promptly, and its common stock will remain listed and traded during the 60-day grace period.
Nasdaq notice received August 20, 2026, for not timely filing the Form 10-Q for the quarter ended June 30, 2026
Company has 60 calendar days from the notice date to submit a plan to regain compliance
If Nasdaq accepts the plan, an exception of up to 180 days from the 10-Q due date, or until February 16, 2027, is possible
Common stock continues to trade on Nasdaq during the grace period, subject to other listing requirements
Planet Green Holdings Corp. disclosed that Curvature Securities, LLC, the agent under an at-the-market (ATM) share sales agreement signed July 13, 2026, gave written notice on August 18, 2026 that it is terminating the agreement effective August 24, 2026. The filing states that no shares had been sold under the agreement as of the notice date, so the termination does not reflect any share issuance to date.
Agreement: ATM Sales Agreement with Curvature Securities, LLC, dated July 13, 2026
Termination notice delivered by the agent on August 18, 2026
Termination effective at close of business on August 24, 2026
No shares of common stock were sold under the agreement as of the notice date
On August 20, 2026, Palo Alto Networks' board approved an Executive Change in Control and Severance Policy covering senior vice presidents and above, including CEO Nikesh Arora and CFO Dipak Golechha. The board also adopted amended and restated bylaws, mainly to align with Delaware law and update routine governance provisions. The filing sets out severance terms but no financial results, so its direct effect on shareholders depends on whether a change in control occurs.
Policy covers executives including CEO Nikesh Arora, CFO Dipak Golechha, President William "BJ" Jenkins and Chief Product and Technology Officer Lee Klarich
CEO severance outside a change-in-control period, after a change in control, or for Good Reason: 200% of salary and 200% of target cash incentive, plus 24 months of health benefits; other executive officers receive 150% and 18 months
Amended and Restated Bylaws took effect immediately on August 20, 2026, and include updates to special board meeting authority and indemnification provisions
Citius Pharmaceuticals received a Nasdaq extension until February 8, 2027 to show its stock closes at or above $1.00 per share, a continued listing requirement. The filing says the extension has no effect on the current listing, but if compliance is not regained by that date, Nasdaq will issue a delisting notice and the company may appeal.
Nasdaq granted an extension to February 8, 2027 for the $1.00 per share bid price requirement under Rule 5550(a)(2)
Compliance requires a closing bid of $1.00 or more for at least ten consecutive business days before February 8, 2027
Common stock will continue trading on the Nasdaq Capital Market under CTXR for now
The company says there can be no assurance it will regain compliance
Adient entered an amendment on August 20, 2026 to its term loan credit agreement, adding $500 million of incremental term loans that bring total loans outstanding to $1.12 billion. The proceeds, with cash on hand, will redeem all $500 million of the 7.000% Senior Secured Notes due 2028 and cover fees and expenses. The filing does not describe a change in the company's operating results.
Amendment dated August 20, 2026 adds $500 million of incremental term loans under the Term Loan Credit Agreement dated May 6, 2019.
Total loans outstanding under the amended credit agreement are $1.12 billion as of the amendment date.
Proceeds plus cash on hand will redeem all $500 million of Adient Global Holdings' 7.000% Senior Secured Notes due 2028.
Incremental term loans have the same maturity and terms as existing term loans and remain secured guarantees by Parent and certain subsidiaries.
Williams Companies director Michael A. Creel notified the company on August 17, 2026 that he will not stand for reelection and will retire from the Board when his current term expires. The filing states his decision is not the result of any disagreement with the company on operations, policies, or practices.
Michael A. Creel notified the company on August 17, 2026 of his decision.
He will not stand for reelection at the 2027 Annual Meeting of Stockholders and will retire upon expiration of his current term.
The filing states the decision is not due to any disagreement with the company.
Home Depot said three executives took on expanded responsibilities, including the CFO leading coordination across its Pro and distribution businesses. On August 20, 2026, the compensation committee granted each of the three executives restricted stock with a grant date fair value of $500,000, vesting on the second anniversary of the grant date. The filing is administrative in nature and does not report financial results or guidance.
William D. Bastek, EVP Merchandising, added the product development merchant portfolio, including private brands.
Jordan Broggi, EVP Interconnected Retail, added loyalty, credit services, and payments.
Richard V. McPhail, EVP and CFO, took on the Office of Pro Acceleration across Home Depot Pro, HD Supply, SRS Distribution, and Construction Resources.
Each executive received restricted stock with a $500,000 grant date fair value, vesting on the second anniversary of the August 20, 2026 grant date.
On August 19, 2026, IMAX amended the employment agreement of Chief Legal Officer and Senior Executive Vice President Robert D. Lister, extending its term to December 31, 2029. The filing says his other compensation and severance terms are unchanged, except for revised treatment of unvested equity awards if he leaves before or after that date. The change is administrative in nature and does not state any new pay amounts.
Amendment dated August 19, 2026 is the third amendment to Lister's agreement, originally dated December 18, 2017.
Employment agreement term extended to December 31, 2029.
If Lister resigns without Good Reason or is terminated for cause before December 31, 2029, unvested equity is cancelled, unless he gave at least six months' written notice of resignation.
The full amendment will be filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2026.
United Fire Group's board declared a $0.20 per share quarterly cash dividend, payable September 18, 2026 to shareholders of record as of September 4, 2026. The board also appointed Teresa "Terri" Brown as an independent Class C director, effective August 21, 2026, bringing the board to 12 members.
Quarterly cash dividend of $0.20 per share, payable September 18, 2026 to holders of record as of September 4, 2026
Teresa "Terri" Brown appointed Class C director effective August 21, 2026, serving on the Risk Management and Audit Committees
Brown was executive vice president and chief financial officer at Grange Insurance from 2016 until her retirement in 2024
Board will consist of 12 members after the appointment
MannKind filed a prospectus supplement to its automatic shelf registration statement on Form S-3 on August 21, 2026, covering the issuance and sale of its common stock. The filing attaches a legal opinion from Cooley LLP on the legality of those share issuances. The filing does not state the size of the offering, the price, or the proceeds.
Prospectus supplement filed August 21, 2026 under Form S-3 Registration No. 333-285286
Exhibit 5.1 is the Cooley LLP opinion on the legality of the common stock issuance
Filing does not state the number of shares, offering price, or proceeds
WhiteFiber completed a $310.0 million private offering of 5.00% convertible senior notes due 2032 on August 21, 2026, including the full $40.0 million option. The company used about $118.5 million of the roughly $298.5 million in net proceeds to exchange $198.15 million of its 4.500% notes due 2031 for cash and about 6.3 million ordinary shares. The new notes add debt and could dilute shareholders on conversion, which the company can settle in cash, shares, or both, and the filing says more project financing will be needed.
$310.0 million principal of 5.00% notes maturing September 1, 2032, with semiannual interest starting March 1, 2027
Initial conversion price of about $33.84 per share, a premium of about 25% over the August 18, 2026 last sale price
Exchanged $198.15 million of 4.500% notes due 2031 for about $118.5 million cash and about 6.3 million ordinary shares, leaving about $31.85 million outstanding
Net proceeds of about $298.5 million; the company says it will require additional project financing, such as construction loans
Breeze Acquisition Corp. II received a Nasdaq notice on August 20, 2026, saying it no longer complies with listing rules because it has not filed its Form 10-Q reports for the quarters ended March 31 and June 30, 2026. The notice has no immediate effect on the listing or trading of the company's securities, but the company must submit a plan to regain compliance by September 21, 2026, and Nasdaq may grant an exception to December 28, 2026, with no assurance that this will happen.
Nasdaq notice received August 20, 2026, citing Listing Rule 5250(c)(1) for late periodic filings
Delinquent Form 10-Qs cover the periods ended March 31, 2026 and June 30, 2026
Compliance plan due September 21, 2026; Nasdaq may grant an exception until December 28, 2026 if the plan is accepted
Notice has no immediate effect on listing or trading; company says it does not assure compliance within the required period
Effective August 17, 2026, Nu Skin said Justin Keisel, its Executive Vice President and President of Global Sales, began a medical leave of absence. Chayce Clark, the company's Executive Vice President, Chief Operating Officer and Chief Legal Officer, will lead Mr. Keisel's organization during his absence. The filing does not state how long the leave will last, so shareholders have no stated return date for the sales leadership role.
Effective date of leave: August 17, 2026
Justin Keisel, EVP and President of Global Sales, began a medical leave of absence
Chayce Clark, EVP, COO and Chief Legal Officer, will lead Keisel's organization during the leave
DarioHealth said President and Chief Commercial Officer Steven Nelson will stop serving in that role on September 1, 2026, and his employment ends September 30, 2026, under a separation agreement signed August 20, 2026. Nelson will then provide consulting services through December 31, 2027, for which the company plans to grant him 30,000 restricted shares, subject to Compensation Committee approval.
Nelson ceases as President and Chief Commercial Officer effective September 1, 2026; employment ends September 30, 2026.
Company will reimburse up to three months of COBRA health coverage at $2,600 per month after the separation date.
Consulting agreement effective October 1, 2026, runs through December 31, 2027, with a grant of 30,000 restricted shares, subject to Compensation Committee approval.
Chaince Digital Holdings Inc. entered into an at-the-market offering agreement on August 19, 2026, allowing it to sell up to $300 million of its ordinary shares through H.C. Wainwright & Co. as sales agent. The filing states the company has no obligation to sell any shares, and the sales agent commission is 3.0% of gross sales, so the program could dilute existing shareholders if used.
Program size: up to $300,000,000 of ordinary shares, par value $0.004 per share
Sales agent: H.C. Wainwright & Co., LLC, paid a 3.0% commission on gross sales price
Company has no obligation to sell shares; it may terminate on ten business days' notice
Issuance runs under Form F-3 shelf (File No. 333-287428) effective June 27, 2025; prospectus supplement filed August 21, 2026
Winnebago Industries and three subsidiaries entered a Third Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. as administrative agent, replacing the 2022 facility and extending its maturity to August 20, 2031. The company reported no borrowings outstanding under the facility, so the change is administrative on its face, though it governs the terms of future borrowing.
Asset-based credit facility of up to $350 million under the existing agreement, now amended and restated
Maturity extended to August 20, 2031; borrowings secured by substantially all assets of the borrowers
Applicable spread of 1.25%-1.75% plus SOFR-based rates; commitment fee of 0.25% per annum
No borrowings outstanding as of the filing; 1.25% spread applies if at least 66% of commitment stays available
GSI Technology's Taiwan subsidiary signed a three-year lease extension on its 25,250 square foot Chu-Pei City facility, which serves as its main Taiwan office and operations site. The company also reported results of its August 20, 2026 annual meeting, where stockholders elected five directors, ratified BDO USA, P.C. as auditor, and approved the advisory executive compensation resolution.
Lease runs September 1, 2026 to August 31, 2029, with monthly rent of NT$605,640 (approximately US$19,015) including tax
Annual meeting held August 20, 2026; all five director nominees were elected, including Elizabeth Cholawsky and Ruey L. Lu
Advisory say-on-pay resolution approved with 15,296,402 votes for and 868,466 against
BDO USA, P.C. ratified as independent registered public accounting firm for fiscal year ending March 31, 2027
Paylocity director Craig Conway told the board on August 20, 2026 that he will not stand for re-election at the company's 2027 annual meeting. He will remain on the board through the end of his current term. The filing says the decision did not stem from any disagreement with the company over its operations, policies or practices.
Conway notified the board on August 20, 2026 of his decision.
The 2027 annual meeting of stockholders is expected to be held on December 3, 2026.
Conway will continue to serve through the remainder of his current term.
The filing states the decision was not due to any disagreement with the company.
VivoSim Labs (VIVS) received a Nasdaq notice on August 17, 2026 saying its stock no longer met the $1 minimum bid price over 30 consecutive business days. The company has 180 calendar days, until February 16, 2027, to regain compliance, and its shares continue to trade on the Nasdaq Capital Market for now. The company has proposed a reverse stock split, which requires stockholder approval, and a failure to regain compliance could lead to delisting proceedings.
Nasdaq notice received August 17, 2026 under Listing Rule 5550(a)(2) for the $1 minimum bid price
Compliance deadline is February 16, 2027; regaining it requires a closing bid of at least $1 for ten consecutive business days
Proposed reverse stock split ratio range of 1-for-5 to 1-for-20, subject to stockholder approval in the 2026 annual meeting proxy
Notice has no immediate effect on listing or trading; ticker remains VIVS
Insteel Industries will close its Upper Sandusky, Ohio welded wire facility and move manufacturing to its remaining welded wire plants, with operations expected to cease by the end of October 2026. The company expects restructuring charges of about $4.6 million, and says the move is not expected to affect its revenue.
Up to 65 positions to be eliminated at the Upper Sandusky facility
Operations expected to cease by the end of October 2026
Expected restructuring charge of approximately $4.6 million, including $1.0 million asset impairment
Cash charges expected to begin in the first quarter of fiscal 2027
Forum Markets director Crystal Heter resigned from the company's Board of Directors and from three board committees, effective August 19, 2026. The company states the resignation was not due to any disagreement with the company on operations, policies, practices, strategy, management or the board, and that she stepped down to focus on her role as President and CEO of Tallgrass Energy, LP, appointed March 27, 2026.
Crystal Heter resigned from the Board effective August 19, 2026
She also left the Audit, Compensation, and Nominating and Corporate Governance Committees
Company states no disagreement led to the resignation
Heter was appointed President and CEO of Tallgrass Energy, LP on March 27, 2026
RenX Enterprises Corp. disclosed that its 50%-owned Norman Berry II Owner, LLC agreed on August 17, 2026 to sell an approximately 7.7-acre property in East Point, Georgia, for $2.6 million to Arbour Valley Development, LLC. Closing depends on conditions including the purchaser receiving state tax credit allocations and obtaining financing, and the company says there is no assurance the sale will close. If it closes as expected, about $800,000 would repay two notes the company holds against the property, and the company's 50% share of the remaining proceeds is expected to be about $900,000.
Purchase price is $2.6 million; the agreement is effective August 17, 2026.
Earnest money deposits of $60,000 each are payable under the agreement, and the sale terminates if the purchaser does not obtain the tax credit allocation it requested.
Purchaser must notify the seller by September 25, 2026 if it will not submit a state application, and has 180 days after the application period to secure financing.
Expected closing proceeds: about $800,000 to repay two notes; about $1.8 million remaining, with RenX's 50% share about $900,000.
Mesa Royalty Trust said on August 21, 2026 that it will pay no distribution for August 2026, because costs, charges and expenses attributable to its royalty properties exceeded the revenue received from the sale of production reported by the working interest owners. The trust also said distributions are expected to be materially reduced until its cash reserves reach $2.0 million, and that accumulated excess production costs will reduce future distributions and may in some periods result in none.
No distribution will be paid for August 2026.
Royalty-property costs and expenses exceeded reported revenue from oil, natural gas and other hydrocarbon sales.
Distributions are expected to be materially reduced until the trust's cash reserves total $2.0 million, per its most recent Form 10-Q.
Substantial accumulated excess production costs will decrease future distributions and may result in none in some periods.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.